or Try an Advanced Search...

    Technical Analysis for HBP - Helix BioPharma Corp.

    Grade Last Price % Change Price Change
    D 0.670 -4.29% -0.030
    HBP closed down 1.41 percent on Wednesday, November 20, 2024, on 1.45 times normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
    Earnings due: Dec 12
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Down Down
    Historical HBP trend table...
    Date Alert Name Type % Chg
    Hammer Candlestick Bullish -4.29%
    MACD Bullish Signal Line Cross Bullish -4.29%
    Lizard Bullish Bullish Day Trade Setup -4.29%
    Wide Bands Range Expansion -4.29%
    1,2,3 Retracement Bearish Bearish Swing Setup -5.63%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -5.63%
    Narrow Range Bar Range Contraction -5.63%
    Wide Bands Range Expansion -5.63%
    Gapped Up Strength -5.63%
    Narrow Range Bar Range Contraction -4.29%
    Older End-of-Day Signals for HBP ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 3 hours ago
    Down 3% about 5 hours ago
    Down 2% about 5 hours ago
    Down 1% about 5 hours ago
    Down 1 ATR 1 day ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    HBP Chart by TradingView
    Basic chart:

    Profile

    Helix BioPharma Corp. Description

    Helix BioPharma Corp. is an immuno-oncology company, which specializes in the field of cancer therapy. The Company is developing products for the prevention and treatment of cancer based on its technologies. The Company's product development initiatives are focused primarily on technologies that modulate the tumor microenvironment. The Company's technology platform, DOS47 yielded approximately two drug product candidates, L-DOS47 and vDOS47. L-DOS47 is an antibody protein conjugate where the urease component enzymatically converts naturally occurring urea to ammonia. L-DOS47 is under clinical study for the treatment of non-small cell lung cancer (NSCLC). L-DOS47 has completed preclinical testing and manufacturing development, following which, regulatory approvals are obtained in Poland and the United States to conduct Phase I/II and Phase I clinical studies. V-DOS47 is an antibody DOS47 conjugate that targets the vascular endothelial growth factor 2 receptor (VEGFR2).

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Manufacturing Medicine Pharma Clinic Drug Cancer Medical Specialties Drugs Therapy Oncology Tumor Lung Cancer Treatment Of Cancer Cancer Immunotherapy Non Small Cell Lung Cancer Product Development Antibody Monoclonal Antibodies Treatment Of Non Small Cell Lung Cancer

    Is HBP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.34
    52 Week Low 0.15
    Average Volume 12,092
    200-Day Moving Average 0.470
    50-Day Moving Average 1.036
    20-Day Moving Average 0.795
    10-Day Moving Average 0.712
    Average True Range 0.094
    RSI (14) 39.76
    ADX 36.82
    +DI 19.791
    -DI 49.034
    Chandelier Exit (Long, 3 ATRs) 1.047
    Chandelier Exit (Short, 3 ATRs) 0.783
    Upper Bollinger Bands 1.092
    Lower Bollinger Band 0.498
    Percent B (%b) 0.34
    BandWidth 74.764
    MACD Line -0.098
    MACD Signal Line -0.100
    MACD Histogram 0.0017
    Fundamentals Value
    Market Cap 93.05 Million
    Num Shares 133 Million
    EPS -0.07
    Price-to-Earnings (P/E) Ratio -10.00
    Price-to-Sales 0.00
    Price-to-Book 18.60
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.940
    Resistance 3 (R3) 0.923 0.827 0.900
    Resistance 2 (R2) 0.827 0.766 0.835 0.887
    Resistance 1 (R1) 0.763 0.728 0.715 0.780 0.873
    Pivot Point 0.667 0.667 0.643 0.675 0.667
    Support 1 (S1) 0.603 0.606 0.555 0.620 0.527
    Support 2 (S2) 0.507 0.568 0.515 0.513
    Support 3 (S3) 0.443 0.507 0.500
    Support 4 (S4) 0.460